Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Novo Nordisk’s Wegovy has shown promising benefits in treating a common, chronic skin condition hidradenitis suppurative (HS) ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

▎药明康德内容团队编辑今天，在2024年欧洲皮肤病和性病学会（EADV）大会上公布的一项开创性研究表明，司美格鲁肽（semaglutide）在治疗肥胖人群的常见慢性皮肤病化脓性汗腺炎（HS）上展现巨大潜力。该研究对2020年6月至2023年3月期间的 ...

▎药明康德内容团队编辑  距离一年一度的诺贝尔奖公布颁奖名单还有两周时间，今年又将有哪些科学成就的重要贡献者获此殊荣？随着明星减肥疗法Wegovy（司美格鲁肽，semaglutide）、Zepboud（tirzepatide）等的爆炸性影响，推动这类 ...

Semaglutide drugs, like Ozempic and Wegovy, may help reduce the risk of an opioid overdose, according to a new study ...

A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

丹麦制药公司诺和诺德（NVO.US）周四表示，欧洲药品管理局（EMA）支持使用该公司畅销药物Wegovy以缓解肥胖患者的心力衰竭。这标志着监管机构第二次支持除减肥外使用Wegovy，并进一步增强了诺和诺德具备多种健康益处的案例。

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...